We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.
- Authors
MacDonald, Roderick; Tacklind, James W; Rutks, Indulis; Wilt, Timothy J
- Abstract
What's known on the subject? and What does the study add? For the past 30 years Serenoa repens has become a widely used phytotherapy in the USA and in Europe, mostly because of positive comparisons to α-blockers and 5α-reductase inhibitors. During the last 4 years we have seen two very high quality trials comparing Serenoa repens to placebo and up to 72 weeks' duration. These trials found Serenoa repens no better than placebo, even (in one trial) at escalating doses.
- Publication
BJU international, 2012, Vol 109, Issue 12, p1756
- ISSN
1464-410X
- Publication type
Journal Article
- DOI
10.1111/j.1464-410X.2012.11172.x